Lessons from a Jehovah's Witness with 5q- syndrome: role of systemic immunosuppression and kinetics of recovery with lenalidomide from a life threatening anaemia.
Robert
R
Cutting
Christopher
C
Dalley
Yousef
Y
Ezaydi
David
D
Winfield
John A
JA
Snowden
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D017353:Gene Deletion; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D033221:Jehovah's Witnesses; D000077269:Lenalidomide; D008875:Middle Aged; D009436:Neural Tube Defects / Q000188:drug therapy* / Q000235:genetics*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide